All posts by BIeditor

Breast Implants, Self-Esteem, Quality of Life, and the Risk of Suicide

Diana Zuckerman, PhD, National Center for Health Research, Caitlin Kennedy, PhD, Mishka Terplan, MD, MPH, Women’s Health Issues: August 2016

Breast augmentation is one of the most common cosmetic surgery in the United States, and many women are encouraged to undergo breast augmentation to improve their lives, self-esteem, or relationships. It is therefore surprising that studies in the United States and Scandinavian countries have shown that suicide rates are higher for women with breast implants.  These studies raise a key question: Do breast implants increase the risk of suicide or do pre-existing mental health problems increase the likelihood of undergoing breast implant surgery and also increase suicide risk?

This article is the first to take a comprehensive look at implants and suicide, by considering information from studies measuring self-esteem, self-concept, mental health, and quality of life among women before and after getting breast implants.

Our 2016 review of all published studies of breast implants and suicide identified 52 articles, but only 7 studies that provided original data on suicide among women with breast implants. All 7 studies found that women with breast implants had much higher suicide rates when compared to women with similar demographic traits – at least double the rate of suicides.  The greatest increase was among postmenopausal women with breast implants, who were 12 times more likely to commit suicide than postmenopausal women without breast implants.  Mastectomy patients with breast implants, many of whom were also post-menopausal, were 10 times as likely to commit suicide compared to mastectomy patients without breast implants. These differences were statistically significant.

Some plastic surgeons and researchers have hypothesized that patients seeking cosmetic surgery have lower self-esteem or tend to be more depressed than other women before they undergo surgery, and that would explain the higher suicide rate among breast implant recipients. However, our analysis of the 7 studies found that other plastic surgery patients were less likely to commit suicide than breast augmentation patients.  The study also found that females who underwent other types of plastic surgery procedures had lower suicide rates than the general female population, when accounting for age and race.  Studies comparing women’s self-esteem, self-identity, and quality of life before and after getting implants also show that these several of these qualities were higher than average prior to breast implant surgery but lower two years after implant surgery.

In other words, the relatively healthy and confident women who get breast implants tend to be less healthy and less confident afterwards. And, they are more likely to commit suicide.  That is true whether they got implants for augmentation or for reconstruction after a mastectomy.

In conclusion, the scientific evidence suggests that breast implants may have risks to mental health. Although suicide among women with implants was below 1% in each of the 7 studies, the rates ranging from 0.24% to 0.68% are significantly higher statistically and clinically than rates for comparable women without breast implants.  And, with millions of women with breast implants, the consistent evidence that women with breast implants are more likely to commit suicide is reason to be very concerned.  The research suggests that women who feel depressed or have low self-esteem should never be encouraged to get breast implants.

The research illustrates the importance of valid and reliable mental health screening to identify women considering breast augmentation who are vulnerable to depression or suicide.  Breast implant surgery should not be considered a strategy to fix low self-esteem or depression. Long-term studies on breast implant patients and depression, anxiety, and self-esteem are needed to give us a better understanding about the impact of implant surgery on women’s mental health and chances of suicide.

Download the article as a pdf here.
Read the original article here.

Crystal Hefner Shares The Health Problems Breast Implants Can Pose

Bruce Y. Lee, Forbes: July 24, 2016.

Crystal Hefner, formerly Crystal Harris and the 30-year-old Playboy model and wife of Playboy founder Hugh Hefner, announced the recent removal of her breast implants by […] sharing a post on Facebook that began, “My Breast Implants Slowly Poisoned Me.” She rattles off a litany of health problems that she says she suffered from the implants such as:

  • Intolerance to foods and beverages
  • Unexplained back pain
  • Constant neck and shoulder pain
  • Cognitive dysfunction (brain fog, memory loss)
  • Stunted hair growth
  • Incapacitating fatigue
  • Burning bladder pain
  • Low immunity
  • Recurring infections
  • Problems with thyroid and adrenals
  • Days  when she couldn’t get out of bed

She explains that at first she was diagnosed with Lyme disease and toxic mold, but then learned via social media that her symptoms resembled “breast implant illness.”

After visiting a breast implant illness website and Facebook group with almost 3,000 members, she realized that her symptoms matched. On June 15th, 2016, plastic surgeon Dr Lu-Jean Feng removed Hefner’s breast implants. […] Her Facebook post continues: ”Instantly I noticed my neck and shoulder pain was gone and I could breathe much better. I know I won’t feel 100% overnight. My implants took 8 years to make me this sick, so I know it will take time to feel better. I also have other illnesses to address, but with the toxic bags removed, my immune system can focus on what it needs to.” […]

Read the original article here. 

Crystal Hefner Removes Breast Implants, Says They ‘Slowly Poisoned’ Her

Chloe Tejada, The Huffington Post CanadaJuly 21, 2016.

[…]On Tuesday, Crystal Hefner posted an update to her social media accounts, revealing to her fans that she removed her breast implants after they caused several major health problems and bad side effects. […]

“My Breast Implants Slowly Poisoned Me,” she titled her post. “Intolerance to foods and beverages, unexplained back pain, constant neck and shoulder pain, cognitive dysfunction (brain fog, memory loss), stunted hair growth, incapacitating fatigue, burning bladder pain, low immunity, recurring infections and problems with my thyroid and adrenals,” she wrote. Hefner went on to explain that symptoms started a few years ago but she ignored them, despite the fact that she was not feeling well.

“The aches, the bladder pain, brain fog, fatigue. I ignored it, labeling myself a hypochondriac, despite truly worrying that there was something wrong with me. I joked about losing my memory to age, and about getting ‘lazy.'”

As the negative side effects worsened, her work as a model and DJ suffered […]

After announcing that she had been diagnosed with Lyme Disease and toxic mold, commenters said her symptoms were similar to the effects of those suffering from Breast Implant Illness.

She became a patient at The Lu-Jean Feng Clinic in Ohio, where, after discussing it with Dr. Lu-Jean Feng, she had her implants removed.

“Instantly I noticed my neck and shoulder pain was gone and I could breathe much better,” she wrote about how she felt after the surgery. “I know I won’t feel 100% overnight. My implants took 8 years to make me this sick, so I know it will take time to feel better. I also have other illnesses to address, but with the toxic bags removed, my immune system can focus on what it needs to.” […]

Here’s to wishing Crystal a safe, and healthy recovery.

Read the original article here. 

Are Bigger Implants Safe? Mentor Receives FDA Approval to Conduct Clinical Trials for Larger Breast Implants

Farzana Akkas, MSc and Diana Zuckerman, PhD, National Center for Health Research

In February 2016, Mentor, a company that makes breast implants, received FDA approval to initiate clinical trials to study the safety and effectiveness of their new and larger memory gel breast implants. Mentor’s memory gel implants are made of an outer silicone shell, filled with clear silicone gel. The largest implants currently available in the U.S. are 800cc, which is about the size of a cantaloupe. The study is enrolling mastectomy patients starting in April 2016 and will evaluate the safety of implants that range in size from 750cc to 1,445cc.

Although silicone gel breast implants have been sold in the U.S. since the 1960’s, they were not approved by the FDA until 20061, after taking them off the market for cosmetic patients in 1992 due to safety concerns. The approval in 2006 was based on research done by breast implant manufacturers such as Mentor and INAMED (later known as Allergan). Since the approval, all breast implants have been found to increase the chances of developing a rare form of lymphoma (cancer of the immune system) known as anaplastic large cell lymphoma (ALCL). 2

Although research linking systemic health consequences and silicone breast implants gives conflicting results, local complications such as rupture, pain, capsular contracture, disfigurement and infection are an obvious complication from breast implants.  Capsular contracture is the most common complication of breast implant surgery, followed by hematoma (blood clot), infection and pain.3, 4 Rupture is considered inevitable if the woman doesn’t replace aging implants.5 The FDA advises women to undergo breast coil MRI tests to check for rupture of silicone gel breast implants starting 3 years after surgery and every 2 years after that.6 This is because most silicone gel breast implants do not show any signs of rupture for several years (this is also known as silent rupture). However, breast coil MRIs are expensive and not usually covered by health insurance.7, 8

The concern about larger silicone gel breast implants, such as the ones being tested by Mentor, is that an enormous amount of silicone could leak into the woman’s body if the implant ruptures. Mentor justifies that larger implants are necessary because larger breasted women who have been diagnosed with breast cancer need them to be consistent with their normal breast size.

As obesity has become more common, more mastectomy patients have requested larger breast implants.  This is particularly likely because women who are overweight are more likely to develop breast cancer. However, those women are also more likely to have a recurrence of breast cancer.  For that reason, obese women who have had breast cancer should be helped to lose weight in order to lower their chances of breast cancer coming back after the surgery.  Replacing a woman’s breast with a very large implant could encourage her to remain overweight, rather than to lose weight.

In addition, if these larger breast implants are approved, however, some women who have never had a mastectomy might choose them for cosmetic reasons.  This would be especially dangerous because research shows that breast implants can interfere with mammography and breast cancer screenings. In addition,  mammography can cause breast implants to rupture.9

The bottom line is that there are still many unanswered questions and conflicting studies on the safety of breast implants. Being able to offer a better size range to larger breasted mastectomy patients certainly does not adequately justify the need for larger breast implants when the negative health consequences are considered. It is important to continue conducting unbiased research to study the complications of breast implants and how implant manufacturers can improve the integrity of their implants to avoid or decrease incidents of complications.

All articles are reviewed and approved by Diana Zuckerman, PhD and other senior staff.

11 Ways Your Breasts Can Change in Your 20s & 30s

Carolyn Steber, Bustle: July 5, 2016.

Breasts can be both a blessing and a curse. And regardless of their size or shape, breasts can change in your 20s and 30s to the point where you may be left stunned, annoyed, or even worried. […]

2. They Will Probably Fluctuate In Size

Breasts can fluctuate in size for a seemingly unending list of reasons. […]

3. They Can Get Stretch Marks

As your breast size changes — due to weight gain, weight loss, or pregnancy — you may notice little lines starting to appear on your skin. These are stretch marks, and they can show up regardless of your age or skin color. […]

4. You May Find Lumps & Bumps

“Fibrocystic change, which is a very common condition characterized by benign lumps in one or both breasts, often emerges when women are in their 20s,” said Zahra Barnes, in an interview with Lisa Jacobs, M.D., on Women’s Health. You should get them checked out, but they are usually nothing to worry about. […]

6. Your Nipples May Protrude

Another post-pregnancy milestone to expect is larger nipples, as well as darker areolas. And these changes can end up being permanent. […]

10. One May Be Larger Than The Other

Most breasts aren’t the same size. The causes are numerous, from misaligned posture, to hormones, to pregnancy. Other times, it may be due to those underlying fibroids, according to Arpana M. Naik, MD, on HealthyWomen.org. […]

11. Your Boobs Become Something To Look After

If you find something concerning, make an appointment with your gynecologist, ASAP. Mammograms aren’t really something you need to think about until you’re 50, according to Diana Zuckerman, Ph.D. and Anna E. Mazzucco, Ph.D. on StopCancerFund.org. If you have a family history of breast cancer, however, those scans may need to start earlier. Talk with your doctor about what’s right for you.

For the most part, being in your 20s and 30s means having healthy, happy boobs. But if any of the above changes occur, do bring it up with your doctor. It’s better to get things checked out, then to assume everything is a-OK […]

Read the original article here.

 

Stephanie March Opens Up About Breast Augmentation Health Scare

Katie Kindelan, ABC News: June 30, 2016.

Actress Stephanie March, best known for playing an assistant district attorney on “Law & Order: SVU,” has opened up about a dangerous reaction she experienced after undergoing breast augmentation.

March, 41, described the episode in a candid essay she wrote for Refinery29. The actress said she decided to have the surgery during a painful time in her life — her split from her then-husband, chef Bobby Flay. […]

March wrote that just two months after the surgery she experienced complications and learned her right implant was infected and the seams of her scar on her right side had burst. Her surgeon removed the implant and sent her to an infectious disease doctor.

“I [had] a hole in my breast for 6 weeks while I blasted my body with antibiotics. I had the implant put back in. I had another infection and rupture on Christmas Eve. I had it taken out again. I had more cultures and tests and conversations with doctors than I care to recall,” March wrote.

March said she came to the conclusion that her complication was not something anyone could have prevented but that, “I am allergic to implants. Plain and simple. My body did. Not. Want. Them. I kept trying to ‘fix’ my body, and it kept telling me to leave it alone.”

The actress, whose divorce from Flay was finalized in July 2015, ultimately had her implants removed. […]

March told ABC News in a statement she is “overwhelmed” and “very moved” by the “positive reaction” to her article.

Dr. Jennifer Ashton, ABC News Chief women’s health correspondent, said today on “Good Morning America” that even common plastic surgery procedures like breast augmentation are “not without complications.”

“You need to know about these possible complications and they do differ based on the type of implant used, the approach used, the incision and generally the skill and the expertise of the surgeon, although these can happen with the best surgical technique,” Ashton said, adding that March noted in her Refinery29 article she did not blame her own surgeon.

Ashton recommends that patients ask their doctor the following three questions before undergoing plastic surgery: Are you board-certified in plastic surgery? How many of these operations you do per year? What is your complication rate?

“If you think that having cosmetic surgery is going to change your life, it’s not,” Ashton added. “And there’s no such thing as minor surgery. You get a complication, it becomes major real fast.”

Read the original article here.

Janice Dickinson Regrets Getting Breast Implants, Believes It Affected Cancer Diagnosis

Ali Venosa, Medical Daily: May 21, 2016.

Breast implants are one of the most popular cosmetic procedures on the planet, but that doesn’t mean they’re never regretted. Supermodel Janice Dickinson, 61, told Entertainment Tonight that when her doctor told her she had stage 1 breast cancer, she wished she never went under the knife.

The mammogram technician added it’s more difficult to detect abnormalities in the breasts when a woman has implants, to which Dickinson replied, “Take them out! Take them out, cut them out! Just take them out now!” Luckily, she doesn’t need to undergo a mastectomy, and instead will begin radiation treatments next week. If she had to do it all over again, Dickinson said she “would have never gotten breast implants in the first place. […]

Though breast implants do not appear to increase a woman’s risk of breast cancer, there may be a link between implants and an increased risk of anaplastic large cell lymphoma (ALCL). In 90 percent of breast cancer cases, women find a breast lump themselves and bring it to the attention of their doctor. With implants, it can be a little more difficult to recognize changes in the breasts. According to one study, 55 percent of breast tumors were missed in women with implants compared to 33 percent of tumors in women without them. […]

For women worried that a mammogram will damage their implants, Bevers said not to worry: The benefits of a mammogram far outweigh any small risk of implant damage. But if women do have them, they should tell their clinician so that it’s easier for them to spot any unusual changes that may be taking place. Regardless of implants, though, the best defense against breast cancer is to be familiar with your breasts and to attend screenings regularly.

Overall, Dickinson herself doesn’t plan on slowing down. It’s not a “big pity party,” she said. “I am living and I am happy.”

Read the original article here.

What if I Need to Get My Implants Removed?


If you want or need to get your implants removed, it is best to choose a board-certified plastic surgeon. Choosing a plastic surgeon to perform your explant surgery requires careful consideration because removal is a more complicated procedure than placing implants.

If you are having any problems with your breast implants, it is especially important to find a surgeon who can remove your implants with great skill. Your surgeon needs to be able to minimize any leakage or other potential problems resulting from the surgery. For more information on finding an experienced plastic surgeon to remove your breast implants, click here.

You may also want to know if insurance will cover the costs of removal. Insurance companies cover services that they determine to be “medically necessary” to treat a disease or illness.  Although you or your doctor may believe a service is medically necessary, insurance companies don’t always agree.

Many companies consider removal of breast implants medically necessary for patients with any of these conditions:

Unfortunately, insurance companies generally won’t cover the cost of breast implant removal for autoimmune or connective tissue diseases or other systemic complications.

Obtaining coverage for your implant removal differs depending on the type of insurance you have. Medicare and Medicaid also cover implant removal that they consider medically necessary. To learn more about trying to get insurance coverage for removal, click here.

The National Center for Health Research is running a free program to assist women to get health insurance coverage to remove their breast implants. If our assistance is something you might be interested in, please fill out this very short survey and we will be in touch with you soon.

Legal Action

Currently, there are no open class action lawsuits relating to implants. Because most women getting implants are asked to sign informed consent documents prior to their surgery, it has become very difficult for lawsuits to proceed. Recently, however, the number of individual lawsuits against breast implant makers has increased. If you believe you may have a claim against an implant manufacturer, you may want to speak to a lawyer who has experience with this type of case.

All articles are reviewed and approved by Diana Zuckerman, PhD, and other senior staff.

Cancer of the Immune System (ALCL) and Breast Implants: Plastic Surgeons Study 173 Women

Brody GS et al., “Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases.” Plastic and Reconstructive Surgery. 2015.

In 2015, plastic surgeons who have been well known for defending the safety of breast implants published a study of 173 women with cancer of the immune system caused by breast implants. 10 The study was paid for by a plastic surgery medical association and written by plastic surgeons who have defended the safety of breast implants for decades.

ALCL (Anaplastic Large Cell Lymphoma) develops near a breast implant but is not breast cancer – it is a cancer of the immune system. The authors of this study point out that the first silicone breast implant was implanted in 1962 and the first publicly reported case of ALCL in a woman with silicone breast implants was in 1997. The authors reviewed 37 medical articles reporting on 79 patients and collected information about an additional 94 women with ALCL caused by breast implants.

Results

Physicians first identified these 173 women with ALCL based on either seromas (a collection of fluid under the skin), a mass attached to the scar capsule surrounding the implant, a tumor that eroded through the skin, in a lymph node near the breast, or discovered during surgery to replace a breast implant. Whether the women had silicone gel or saline breast implants didn’t seem to make a difference, but many of the women had at least one textured breast implant.  Cosmetic augmentation patients and women who had breast implants to reconstruct their breasts after undergoing a mastectomy were both at risk of developing ALCL because of their implants. Of the women whose ALCL spread outside of their scar capsule surrounding the implant, about half died from ALCL.

The authors pointed out that ALCL can be difficult to diagnose. Although the fluid and scar capsule usually appear abnormal, they sometimes look normal. The authors recommend “that all fluid and capsule tissue from patients with seromas” should be tested for ALCL. They point out that if the tumor is inside the capsule, removing both implants and the capsules may be the only treatment necessary. However, if the tumor has developed just outside the capsule, chemotherapy with or without radiation is needed and usually effective. Unfortunately, aggressive ALCL that has spread beyond the scar capsule area is usually fatal, regardless of treatment.

2017 Update

In March 2017, the U.S. Food and Drug Administration (FDA) reported that it had received 359 reports of ALCL among women with breast implants. Unfortunately, many cases of ALCL are not reported to the FDA.  The FDA’s announcement came after the World Health Organization (WHO) officially recognized “breast implant associated ALCL (BIA-ALCL)” in 2016. In 2014, the National Comprehensive Cancer Network (NCCN) has also released a worldwide oncology standard for surgeons and oncologists to test for and diagnose the disease.

2022 Update

In April 2022, The FDA announced it hade received  1,130 reports of BIA-ALCL and of those cases, 59 reported deaths. The FDA continues to receive reports of BIA-ALCL across the globe.

 

Read the original study here. 

To read more about what you need to know about ALCL, click here.

Next Steps for Breast Implant–Associated Anaplastic Large-Cell Lymphoma

Anna E. Mazzucco. “Next steps for breast implant–associated anaplastic large-cell lymphoma.” Journal of Clinical Oncology: June 16, 2014

To the Editor:

The excellent analysis by Miranda et al 11.based on extended follow-up of patients with breast implant-associated anaplastic large-cell lymphoma (ALCL) adds to the mounting evidence of the potential for aggressive clinical behavior of this disease.2,3For the first time, these researchers identified two patient subpopulations with distinct clinical outcomes: 75% of the patients with solid ALCL tumors had survived at 5 years postdiagnosis, compared with 100% of patients with effusion-type ALCL. In contrast, earlier studies suggested that breast implant–associated ALCL was likely to be clinically indolent and more similar to primary cutaneous, anaplastic lymphoma kinase (ALK) –negative ALCL, rather than the more aggressive systemic form of the disease.4,5

Although ALCL is rare, breast implants increase the risk by an estimated odds ratio of 18.2.6,7 Miranda et al1 found aggressive ALCL and potential mortalities associated with either saline or silicone-filled implants in both cosmetic and reconstruction patients, and point out that the lack of routine pathology examination of seroma or excised tissue could result in an underestimation of ALCL occurrence. Extrapolating from their findings, the lack of routine pathology is likely to delay the diagnosis when women with implants seek medical care from plastic surgeons or primary care physicians for swollen breasts that are assumed to be infected.

Timely diagnosis will depend on the millions of women with breast implants having access to heightened surveillance, knowledgeable physicians, and appropriate testing and medical care. All of the ALCL cases described in Miranda et al1 were ALK negative, which has a poor overall prognosis and is treated with cytotoxic chemotherapy.8 Others have proposed that all seromas associated with implants, especially those which are therapy resistant, should therefore be carefully monitored, and any patient presenting with recurrent seroma 6 months or more after implantation should undergo aspirate analysis without delay.9,10 The question is, how can such monitoring be ensured?

The track record for monitoring the health of patients with breast implants is not encouraging, however. For example, the US Food and Drug Administration recommends that all women with silicone gel breast implants undergo regular magnetic resonance imaging scans starting 3 years after implantation to check for implant rupture, but most insurance policies do not cover such screening; therefore, few women follow these guidelines. Moreover, many health insurance policies currently exclude any services related to complications from cosmetic surgery; this excludes the approximately 75% of women whose breast implants were originally for cosmetic purposes rather than reconstruction after mastectomy. Our research center’s recent review of health care policies under the Affordable Care Act found no evidence that the growing literature on breast implant–associated ALCL has influenced health insurance coverage for either cytology cultures of seroma or removal of breast implants and capsules that are causing ALCL.

Future studies are needed to elucidate what factors determine whether specific types of breast implants are more likely to increase the risk of ALCL, particularly solid tumors. The collaboration between the US Food and Drug Administration and the American Society of Plastic Surgeons to create a registry of implant recipients who develop ALCL should provide useful information. As new data become available, they should quickly be used to improve early diagnosis and treatment. That will require insurance coverage of medically necessary services for women with serious breast implant complications, including those with implants originally for cosmetic purposes.

Read the original article here.

 

  1. RN Miranda, TN Aladily, HM Prince , et al. Breast implant–associated anaplastic large-cell lymphoma: Long-term follow-up of 60 patients. J Clin Oncol. 32: 114– 120, 2014. Google Scholar
  2. Carty MJPribaz JJAntin JHet al. (2011) A patient death attributable to implant-related primary anaplastic large cell lymphoma of the breast. Plast Reconstr Surg 128:112e118eCrossRefMedlineGoogle Scholar
  3. George EVPharm JHouston Cet al. (2013) Breast implant-associated ALK-negative anaplastic large cell lymphoma: A case report and discussion of possible pathogenesis. Int J Clin Exp Pathol 6:16311642MedlineGoogle Scholar
  4. Aladily TNMedeiros LJAlayed Ket al. (2012) Breast implant-associated anaplastic large cell lymphoma: A newly recognized entity that needs further refinement of its definition. Leuk Lymphoma 53:749750CrossRefMedlineGoogle Scholar
  5. Ralfkiaer EWillemze RPaulli Met al. (2008) in Tumours of the Hematopoietic and Lymphoid Tissues (ed 4) Primary cutaneous CD30 T-cell lymphoproliferative disorders, eds Swerdlow SH, Campo E, Harris NL, et al.(International Agency for Research on Cancer, Lyon, France), pp 300301Google Scholar
  6. US Food and Drug Administration. Anaplastic Large Cell Lymphoma (ALCL) In Women with Breast Implants: Preliminary FDA Findings and Analyses, 2011.http://www.fda.gov/medicaldevices/productsandmedicalprocedures/implantsandprosthetics/breastimplants/ucm239996.htm.
  7. de Jong DVasmel WLde Boer JPet al. (2008) Anaplastic large-cell lymphoma in women with breast implants. JAMA 300:20302035CrossRefMedlineGoogle Scholar
  8. ten Berge RLde Bruin PCOudejans JJet al. (2003) ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified. Histopathology 43:462469CrossRefMedlineGoogle Scholar
  9. Kim BRoth CYoung VLet al. (2011) Anaplastic large cell lymphoma and breast implants: Results from a structured expert consultation process. Plast Reconstr Surg 128:629639CrossRefMedlineGoogle Scholar
  10. Taylor KOWebster HRPrince HM